A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study-Reference-Cited by-同舟云学术

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study

Published:2018-08-16 Issue:12 Volume:20 Page:2876-2884
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Scott Russell¹,Morgan Jerry²,Zimmer Zachary²,Lam Raymond L. H.²,O'Neill Edward A.²,Kaufman Keith D.²,Engel Samuel S.²^ORCID,Raji Annaswamy²^ORCID

Affiliation:

1. Lipid and Diabetes Research Group, Christchurch School of Medicine; Christchurch New Zealand

2. Merck & Co., Inc.; Kenilworth New Jersey

Funder

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13473/fullpdf

Reference25 articles.

1. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on kidney disease: improving global outcomes (KDIGO) staging;Bailey;BMC Res Notes,2014

2. Management of diabetes mellitus in patients with chronic kidney disease;Hahr;Clin Diabetes Endocrinol,2015

3. A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials;Deacon;Diabetes Obes Metab,2018

4. Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties;Arnouts;Nephrol Dial Transplant,2014

5. A new equation to estimate glomerular filtration rate;Levey;Ann Intern Med,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Observational Study on Assessing Sitagliptin and Dapagliflozin as a Fixed-Dose Combination in the Indian Population With Type 2 Diabetes Mellitus: The SIDAXA Study;Cureus;2024-05-21

2. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

3. Vital role of CYP450 in the biodegradation of antidiabetic drugs in the aerobic activated sludge system and the mechanisms;Journal of Hazardous Materials;2024-05

4. An Overview of Dapagliflozin;International Journal of Innovative Science and Research Technology (IJISRT);2024-04-30

5. Prusogliptin (DBPR108) monotherapy in treatment‐naïve patients with type 2 diabetes: A randomized, double‐blind, active and placebo‐controlled, phase 3 study;Diabetes, Obesity and Metabolism;2024-01-15